-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $27.5

Benzinga·08/04/2026 12:12:07
語音播報
Piper Sandler analyst David Westenberg maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price target from $20 to $27.5.